$9.62
At close: Feb 4, 7:47 PM EDT
$9.67
0.050.54%
After Hours: 7:47 PM EDT
Intellia Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Intellia Therapeutics using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-07 | $-1.34 | $-1.38 | 2.90 % |
Q2 | 2024-08-08 | $-1.52 | $-1.23 | -23.6 % |
Q1 | 2024-05-09 | $-1.12 | $-1.38 | 18.8 % |
Q4 | 2024-02-22 | $-1.46 | $-1.45 | -0.69 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-07 | $9.11M | $7.86M | 15.9 % |
Q2 | 2024-08-08 | $6.96M | $19.16M | -63.7 % |
Q1 | 2024-05-09 | $28.94M | $11.50M | 151.6 % |
Q3 | 2023-11-09 | $11.99M | $12.45M | -3.68 % |
Intellia Therapeutics (NTLA) is scheduled to report earnings on February 20, 2025. The last reported earnings were for reported on November 7, 2024 for Q3.
The Actual EPS was $-1.34, which beat the estimate of $-1.38.
The Actual Revenue was $9.1M, which beat the estimate of $7.9M.
Browse earnings estimates, EPS, and revenue on all stocks.